be in the form of a sterile injectable liquid such as an ampule or an aqueous or non aqueous liquid suspension for oral administration the pharmaceutical composition will be in the form of a tablet capsule powder pellet atroche lozenge syrup liquid or emulsion when the pharmaceutical composition is employed in the form of a solution or suspension examples of appropriate pharmaceutical carriers or diluents include for aqueous systems water for non aqueous systems ethanol glycerin propylene glycol corn oil cottonseed oil peanut oil sesame oil liquid parafins and mixtures thereof with water for solid systems lactose kaolin and mannitol and for aerosol systems dichlorodifluoromethane chlorotrifluoroethane and compressed carbon dioxide also in addition to the pharmaceutical carrier or diluent the instant compositions may include other ingredients such as stabilizers antioxidants preservatives lubricants suspending agents viscosity modifiers and the like provided that the additional ingredients do not have a detrimental effect on the therapeutic action of the instant compositions the pharmaceutical preparations thus described are made following the conventional techniques of the pharmaceutical chemist as appropriate to the desired end product in these compositions the amount of carrier or diluent will vary but preferably will be the major proportion of a suspension or solution of the active ingredient when the diluent is a solid it may be present in lesser equal or greater amounts than the solid active ingredient usually a compound of formula i or ii is administered to a subject in a composition comprising a nontoxic amount sufficient to produce an inhibition of the symptoms of a disease in which leukotrienes are a factor topical formulations will contain between about.